Peter L. Fishman - 01 Aug 2025 Form 4 Insider Report for AMARIN CORP PLC\UK (AMRN)

Role
SVP, CFO
Signature
/s/ Jonathan Provoost, by power of attorney
Issuer symbol
AMRN
Transactions as of
01 Aug 2025
Net transactions value
-$2,323
Form type
4
Filing time
04 Aug 2025, 17:00:06 UTC
Previous filing
09 Apr 2025
Next filing
06 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fishman Peter L. SVP, CFO C/O AMARIN PHARMA, INC., 440 US HIGHWAY 22, BRIDGEWATER /s/ Jonathan Provoost, by power of attorney 04 Aug 2025 0002042862

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRN American Depositary Share Options Exercise +312 +8.1% 4,148 01 Aug 2025 Direct F1, F2, F3
transaction AMRN American Depositary Share Tax liability $2,323 -160 -3.9% $14.52 3,988 01 Aug 2025 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRN Restricted Stock Unit Award $0 +312 +31200% $0.000000 313 01 Aug 2025 American Depositary Shares 312 $0.000000 Direct F1, F2, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change.
F2 On August 8, 2022, the Reporting Person was granted 1,250 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in four equal installments on each of August 1, 2023, August 1, 2024, August 1, 2025, and August 1, 2026.
F3 Not applicable.
F4 Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
F5 Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion.